Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-02 13:47:33 - browse：4

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Merck to acquire Harpoon Therapeutics for $680 million

leisure time

WSS

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Cigna, Humana reportedly in talks to merge

Ascension's ugly legal battle over care for poor patients in Texas

Arena BioWorks launches in Cambridge to speed drug discovery

Organ aging and disease risk measured by new blood test

What don’t we know about an Alzheimer’s drug side effect?

Wikipedia

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

U.K. Biobank has 500,000 peoples' genome sequences available

ChatGPT in medicine: STAT answers readers' burning questions

As biotech industry slumps, bioscience job market is upside down

State Dept. review finds Biden bears some blame for Afghanistan failures

CDC director unscathed in first congressional testimony

New air purifier tech could be key to improving indoor air quality

American taxpayers paid $1.8 trillion in health care costs in 2022

Psychedelics group wrestles with new pharma identity

What don’t we know about an Alzheimer’s drug side effect?

hotspot

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Rep. Raul Ruiz on the physician shortage and more

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Flagship Pioneering launches a new biotech in two countries

U.K. Biobank has 500,000 peoples' genome sequences available

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

knowledge

hotspot

leisure time

focus